////// Science for a better life Global Fighting Prostate Cancer New Approaches for Better Treatment Outcomes READ MORE Enter Search term Explore Your Topic The Bio Revolution Redefining Innovation in Life Sciences READ MORE Climate Change Our Net Zero Target and How We Get There READ MORE November 9, 2021 Q3 2021 Results QUARTERLY STATEMENT Q3 MEDIA CONFERENCE CALL - RECORDING INVESTOR CONFERENCE CALL - RECORDING A Z Our Products READ MORE Megatrends Changing the Future Can we solve the unsolvable? READ MORE Bayer Strengthens Drug Discovery Platform through Acquisition of Vividion Therapeutics READ MORE Roundup™ Five-Point Plan to Closure of Litigation READ MORE TWITTER Bayer Thursday, November 25, 2021 RT @berninger71: #COP26 will probably help limit global warming, but at a level above the 1.5°C scenario. How can we reduce every greenhous… READ MORE Uses and Safety Record Let’s Talk About Glyphosate READ MORE SHOW MORE Inform Yourself on Special Topics CORONAVIRUS Our Contribution to Fighting the COVID-19 Pandemic READ MORE INFORMATION FOR PATIENTS The Benefits and Risks of Medicines READ MORE RELEVANT POSITIONS Modern Slavery Act Statement READ MORE Latest News Share Price / Index Bayer December 3, 2021 17:35 CEST 44.26 -1.51 % DAX December 3, 2021 17:55 CEST 15,169.98 -0.61 % December 03, 2021 Not intended for U.S. and UK Media Phase III trial with Nubeqa™ (darolutamide) in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer READ MORE November 15, 2021 Not intended for U.S. and UK Media Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease READ MORE November 11, 2021 Not intended for U.S. and UK Media New Phase III study to investigate expanded use of vericiguat in patients with chronic heart failure with reduced ejection fraction READ MORE NEWS OVERVIEW Advance Your Career Career Why Bayer READ MORE Working at Bayer Meet Our Employees READ MORE Job Search READ MORE Explore Our Businesses We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here. Pharmaceuticals READ MORE Consumer Health READ MORE Crop Science READ MORE Find Your Product With our products we contribute to the health of people and plants. Here you find an overview of the major Bayer products. A Field of Activity Application A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ALL PRODUCTS Z Last Updated: Friday, December 03, 2021 Our Business Pharmaceuticals Consumer Health Crop Science Our Products Bayer Worldwide Magazines & Reports News & Stories Annual Report Quarterly Report More Publications Stay Tuned Job Postings Latest News Newsletter Bayer Share Price Get in Touch Do you have any queries or comments? GLOBAL FORM REPORT A SIDE EFFECT Follow Us Copyright © Bayer AG Conditions of Use Privacy Statement Cookie Settings Imprint Sitemap Usage of Cookies We would like to use optional cookies to better understand your use of this website, to improve our website and to share information with our advertising partners. Detailed information about the use of strictly necessary cookies, which are essential to browse this website, and optional cookies, which you can reject or accept below, and how you can manage or withdraw your consent at any time can be found in our Privacy Statement. COOKIE SETTINGS REJECT COOKIES ACCEPT COOKIES